These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
224 related articles for article (PubMed ID: 14751925)
1. Stroke and conversion to high risk in children screened with transcranial Doppler ultrasound during the STOP study. Adams RJ; Brambilla DJ; Granger S; Gallagher D; Vichinsky E; Abboud MR; Pegelow CH; Woods G; Rohde EM; Nichols FT; Jones A; Luden JP; Bowman L; Hagner S; Morales KH; Roach ES; Blood; 2004 May; 103(10):3689-94. PubMed ID: 14751925 [TBL] [Abstract][Full Text] [Related]
2. Can peak systolic velocities be used for prediction of stroke in sickle cell anemia? Jones A; Granger S; Brambilla D; Gallagher D; Vichinsky E; Woods G; Berman B; Roach S; Nichols F; Adams RJ Pediatr Radiol; 2005 Jan; 35(1):66-72. PubMed ID: 15517239 [TBL] [Abstract][Full Text] [Related]
3. Transcranial Doppler velocity and brain MRI/MRA changes in children with sickle cell anemia on chronic transfusions to prevent primary stroke. Sheehan VA; Hansbury EN; Smeltzer MP; Fortner G; McCarville MB; Aygun B Pediatr Blood Cancer; 2013 Sep; 60(9):1499-502. PubMed ID: 23625812 [TBL] [Abstract][Full Text] [Related]
4. Comparison of transcranial color Doppler imaging (TCDI) and transcranial Doppler (TCD) in children with sickle-cell anemia. Jones AM; Seibert JJ; Nichols FT; Kinder DL; Cox K; Luden J; Carl EM; Brambilla D; Saccente S; Adams RJ Pediatr Radiol; 2001 Jul; 31(7):461-9. PubMed ID: 11486797 [TBL] [Abstract][Full Text] [Related]
5. Effect of transfusion therapy on transcranial Doppler ultrasonography velocities in children with sickle cell disease. Kwiatkowski JL; Yim E; Miller S; Adams RJ; Pediatr Blood Cancer; 2011 May; 56(5):777-82. PubMed ID: 21370410 [TBL] [Abstract][Full Text] [Related]
6. Transcranial Doppler (TCD) screening for stroke prevention in sickle cell anemia: pitfalls in technique variation. Bulas DI; Jones A; Seibert JJ; Driscoll C; O'Donnell R; Adams RJ Pediatr Radiol; 2000 Nov; 30(11):733-8. PubMed ID: 11100487 [TBL] [Abstract][Full Text] [Related]
7. Evaluation of a comprehensive transcranial doppler screening program for children with sickle cell anemia. McCarville MB; Goodin GS; Fortner G; Li CS; Smeltzer MP; Adams R; Wang W Pediatr Blood Cancer; 2008 Apr; 50(4):818-21. PubMed ID: 18085672 [TBL] [Abstract][Full Text] [Related]
8. Stroke prevention in sickle cell disease (STOP) study guidelines for transcranial Doppler testing. Nichols FT; Jones AM; Adams RJ J Neuroimaging; 2001 Oct; 11(4):354-62. PubMed ID: 11677874 [TBL] [Abstract][Full Text] [Related]
9. Stroke Prevention Trial in Sickle Cell Anemia (STOP): extended follow-up and final results. Lee MT; Piomelli S; Granger S; Miller ST; Harkness S; Brambilla DJ; Adams RJ; Blood; 2006 Aug; 108(3):847-52. PubMed ID: 16861341 [TBL] [Abstract][Full Text] [Related]
10. Hydroxyurea lowers transcranial Doppler flow velocities in children with sickle cell anaemia in a Nigerian cohort. Lagunju I; Brown BJ; Sodeinde O Pediatr Blood Cancer; 2015 Sep; 62(9):1587-91. PubMed ID: 25847050 [TBL] [Abstract][Full Text] [Related]
11. Transcranial Doppler Screening in a Current Cohort of Children With Sickle Cell Anemia: Results From the DISPLACE Study. Kanter J; Phillips S; Schlenz AM; Mueller M; Dooley M; Sirline L; Nickel R; Brown RC; Hilliard L; Melvin CL; Adams RJ J Pediatr Hematol Oncol; 2021 Nov; 43(8):e1062-e1068. PubMed ID: 33625093 [TBL] [Abstract][Full Text] [Related]
12. Hydroxyurea therapy lowers transcranial Doppler flow velocities in children with sickle cell anemia. Zimmerman SA; Schultz WH; Burgett S; Mortier NA; Ware RE Blood; 2007 Aug; 110(3):1043-7. PubMed ID: 17429008 [TBL] [Abstract][Full Text] [Related]
13. Big strokes in small persons. Adams RJ Arch Neurol; 2007 Nov; 64(11):1567-74. PubMed ID: 17998439 [TBL] [Abstract][Full Text] [Related]
14. TCD in sickle cell disease: an important and useful test. Adams RJ Pediatr Radiol; 2005 Mar; 35(3):229-34. PubMed ID: 15703904 [TBL] [Abstract][Full Text] [Related]
15. Transcranial doppler re-screening of subjects who participated in STOP and STOP II. Adams RJ; Lackland DT; Brown L; Brown D; Voeks J; Fullerton HJ; Kanter J; Kwiatkowski JL Am J Hematol; 2016 Dec; 91(12):1191-1194. PubMed ID: 27623561 [TBL] [Abstract][Full Text] [Related]
16. Problems with implementing a standardised transcranial Doppler screening programme: impact of instrumentation variation on STOP classification. Padayachee ST; Thomas N; Arnold AJ; Inusa B Pediatr Radiol; 2012 Apr; 42(4):470-4. PubMed ID: 22002844 [TBL] [Abstract][Full Text] [Related]
17. Capacity building and stroke risk assessment in Nigerian children with sickle cell anaemia. Soyebi K; Adeyemo T; Ojewunmi O; James F; Adefalujo K; Akinyanju O Pediatr Blood Cancer; 2014 Dec; 61(12):2263-6. PubMed ID: 25174615 [TBL] [Abstract][Full Text] [Related]
18. Transcranial Doppler changes in children with sickle cell disease on transfusion therapy. Minniti CP; Gidvani VK; Bulas D; Brown WA; Vezina G; Driscoll MC J Pediatr Hematol Oncol; 2004 Oct; 26(10):626-30. PubMed ID: 15454832 [TBL] [Abstract][Full Text] [Related]
19. Practice patterns for stroke prevention using transcranial Doppler in sickle cell anemia: DISPLACE Consortium. Schlenz AM; Phillips S; Mueller M; Melvin C; Adams RJ; Kanter J; Pediatr Blood Cancer; 2020 Apr; 67(4):e28172. PubMed ID: 31925913 [TBL] [Abstract][Full Text] [Related]
20. Prevention of conversion to abnormal transcranial Doppler with hydroxyurea in sickle cell anemia: A Phase III international randomized clinical trial. Hankins JS; McCarville MB; Rankine-Mullings A; Reid ME; Lobo CL; Moura PG; Ali S; Soares DP; Aldred K; Jay DW; Aygun B; Bennett J; Kang G; Goldsmith JC; Smeltzer MP; Boyett JM; Ware RE Am J Hematol; 2015 Dec; 90(12):1099-105. PubMed ID: 26414435 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]